Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hee Dong Han

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Journal of Ginseng Research|May 30, 2023
KRG and its major ginsenosides do not show distinct steroidogenic activities examined by the OECD test guideline 440 and 456 assaysNamkyu Lee, Ju Hyeong Lee, Ji Eun Won, et al.
International Journal of Nanomedicine|November 5, 2020
Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian CarcinomaTae In Wi, Ji Eun Won, Chan Mi Lee, et al.
Immune Network|November 8, 2013
Nanoparticle-based vaccine delivery for cancer immunotherapyYeong-Min Park, Seung Jun Lee, Young Seob Kim, et al.
Experimental & Molecular Medicine|December 10, 2020
Interactions between tumor-derived proteins and Toll-like receptorsGun-Young Jang, Ji Won Lee, Young Seob Kim, et al.
The Journal of Biological Chemistry|August 3, 2012
N-methyl-D-aspartate receptor- and calpain-mediated proteolytic cleavage of K+-Cl- cotransporter-2 impairs spinal chloride homeostasis in neuropathic painHong-Yi Zhou, Shao-Rui Chen, Hee-Sun Byun, et al.
Human Pathology|March 23, 2012
Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancerYaser R Hussein, Anil K Sood, Sudeshna Bandyopadhyay, et al.
Anticancer Research|September 30, 2024
Anticancer Effects of BAF312 (Siponimod) in Epithelial Ovarian CancerHeeeun Ha, Ji-Yoon Ryu, Suin Yoon, et al.
International Immunopharmacology|June 8, 2019
Drug repositioning of TANK-binding kinase 1 inhibitor CYT387 as an alternative for the treatment of Gram-negative bacterial sepsisSeung Jun Lee, Amal Gharbi, Jueng Soo You, et al.
Cancer Biology & Therapy|March 2, 2011
Chitosan hydrogel for localized gene silencingHee Dong Han, Edna M Mora, Ju Won Roh, et al.
International Journal of Nanomedicine|November 16, 2016
Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapyHee Dong Han, Yeongseon Byeon, Tae Heung Kang, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Journal of Ginseng Research|May 30, 2023
KRG and its major ginsenosides do not show distinct steroidogenic activities examined by the OECD test guideline 440 and 456 assaysNamkyu Lee, Ju Hyeong Lee, Ji Eun Won, et al.
International Journal of Nanomedicine|November 5, 2020
Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian CarcinomaTae In Wi, Ji Eun Won, Chan Mi Lee, et al.
Immune Network|November 8, 2013
Nanoparticle-based vaccine delivery for cancer immunotherapyYeong-Min Park, Seung Jun Lee, Young Seob Kim, et al.
Experimental & Molecular Medicine|December 10, 2020
Interactions between tumor-derived proteins and Toll-like receptorsGun-Young Jang, Ji Won Lee, Young Seob Kim, et al.
The Journal of Biological Chemistry|August 3, 2012
N-methyl-D-aspartate receptor- and calpain-mediated proteolytic cleavage of K+-Cl- cotransporter-2 impairs spinal chloride homeostasis in neuropathic painHong-Yi Zhou, Shao-Rui Chen, Hee-Sun Byun, et al.
Human Pathology|March 23, 2012
Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancerYaser R Hussein, Anil K Sood, Sudeshna Bandyopadhyay, et al.
Anticancer Research|September 30, 2024
Anticancer Effects of BAF312 (Siponimod) in Epithelial Ovarian CancerHeeeun Ha, Ji-Yoon Ryu, Suin Yoon, et al.
International Immunopharmacology|June 8, 2019
Drug repositioning of TANK-binding kinase 1 inhibitor CYT387 as an alternative for the treatment of Gram-negative bacterial sepsisSeung Jun Lee, Amal Gharbi, Jueng Soo You, et al.
Cancer Biology & Therapy|March 2, 2011
Chitosan hydrogel for localized gene silencingHee Dong Han, Edna M Mora, Ju Won Roh, et al.
International Journal of Nanomedicine|November 16, 2016
Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapyHee Dong Han, Yeongseon Byeon, Tae Heung Kang, et al.
Pageof 12